Familial Hypercholesterolemia News and Research

RSS
Genzyme, Isis receive 2014 Partners in Progress Corporate Award for KYNAMRO injection

Genzyme, Isis receive 2014 Partners in Progress Corporate Award for KYNAMRO injection

Controlling low-density lipoprotein-cholesterol levels: an interview with Jay Edelberg, M.D., Sanofi and Bill Sasiela, Ph.D., Regeneron

Controlling low-density lipoprotein-cholesterol levels: an interview with Jay Edelberg, M.D., Sanofi and Bill Sasiela, Ph.D., Regeneron

Synageva announces publication of LAL Deficiency review in Atherosclerosis

Synageva announces publication of LAL Deficiency review in Atherosclerosis

Clinical Research Forum announces winners of third annual Top 10 Clinical Research Achievement Awards

Clinical Research Forum announces winners of third annual Top 10 Clinical Research Achievement Awards

Two Penn researchers selected as recipients of prestigious Clinical Research Achievement Award

Two Penn researchers selected as recipients of prestigious Clinical Research Achievement Award

Amgen reports positive findings from AMG 145 Phase 3 studies in patients at risk for cardiovascular disease

Amgen reports positive findings from AMG 145 Phase 3 studies in patients at risk for cardiovascular disease

Findings underscore importance of universal pediatric cholesterol screening

Findings underscore importance of universal pediatric cholesterol screening

Amgen announces results from Phase 3 TESLA Trial of evolocumab in patients with HoFH

Amgen announces results from Phase 3 TESLA Trial of evolocumab in patients with HoFH

Liposorber LA-15 System to treat pediatric patients with primary FSGS gets FDA approval

Liposorber LA-15 System to treat pediatric patients with primary FSGS gets FDA approval

Expert offers tips to help college students avoid serious health conditions down the road

Expert offers tips to help college students avoid serious health conditions down the road

Merck's LIPTRUZET tablets get FDA approval for treatment of elevated LDL cholesterol

Merck's LIPTRUZET tablets get FDA approval for treatment of elevated LDL cholesterol

Investigational treatment for ALS passes early phase clinical trial for safety

Investigational treatment for ALS passes early phase clinical trial for safety

LDL apheresis can reduce cholesterol levels in patients with familial hypercholesterolemia

LDL apheresis can reduce cholesterol levels in patients with familial hypercholesterolemia

Genetic testing strategy for familial high cholesterol questioned

Genetic testing strategy for familial high cholesterol questioned

FDA approves Genzyme’s KYNAMRO to treat homozygous familial hypercholesterolemia

FDA approves Genzyme’s KYNAMRO to treat homozygous familial hypercholesterolemia

Genzyme receives FDA approval for Kynamro to treat homozygous familial hypercholesterolemia

Genzyme receives FDA approval for Kynamro to treat homozygous familial hypercholesterolemia

Juxtapid receives FDA approval for treatment of rare cholesterol disorder

Juxtapid receives FDA approval for treatment of rare cholesterol disorder

Data from four Phase 2 trials of AMG 145 to be presented at AHA Scientific Sessions 2012

Data from four Phase 2 trials of AMG 145 to be presented at AHA Scientific Sessions 2012

Lomitapide shows promise in treating homozygous familial hypercholesterolemia

Lomitapide shows promise in treating homozygous familial hypercholesterolemia

University of Cambridge forms new spin-out company to supply hIPSC-derived cells

University of Cambridge forms new spin-out company to supply hIPSC-derived cells